Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Antiplatelet agents in coronary artery disease
B. J. Schrader,
S. I. Berk
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antiplatelet agents in coronary artery disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Platelet Aggregation Inhibitors
77%
Aspirin
62%
Coronary Artery Disease
56%
Blood Platelets
42%
Myocardial Infarction
29%
Infarction
22%
Sulfinpyrazone
22%
Thromboxane-A Synthase
20%
Mortality
20%
Prostaglandin H2 Receptors Thromboxane A2
19%
Streptokinase
17%
Dipyridamole
16%
Angina Pectoris
15%
Epoprostenol
15%
Non-Steroidal Anti-Inflammatory Agents
14%
Prostaglandin-Endoperoxide Synthases
14%
Primary Prevention
14%
Cyclic AMP
13%
Prostaglandins
12%
Pharmaceutical Preparations
11%
Eating
10%
Placebos
9%
Stroke
9%
Retrospective Studies
9%
Clinical Trials
8%
Hemorrhage
8%
Survival
7%
Enzymes
7%
Therapeutics
4%
Chemical Compounds
Antithrombocytic Agent
100%
Sulfinpyrazone
40%
Dipyridamole
33%
Thromboxane A2
33%
Thromboxane
32%
Anticoagulant Agent
29%
Nonsteroid Antiinflammatory Agent
26%
Prostaglandin
25%
Drug
23%
Dose
17%
Reduction
10%